Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Characterization of HIV-1 Subtypes Among South Sudanese Patients.

Lo Presti A, Farcomeni S, Fontanelli Sulekova L, Grieco S, Sernicola L, Baesso M, Maggiorella MT, Angeletti S, Foley B, Ciccozzi M, Taliani G, Borsetti A.

AIDS Res Hum Retroviruses. 2019 Oct;35(10):968-971. doi: 10.1089/AID.2019.0133. Epub 2019 Aug 8.

PMID:
31280584
2.

Genetic diversity in the env V1-V2 region of proviral quasispecies from long-term controller MHC-typed cynomolgus macaques infected with SHIVSF162P4cy.

Capone A, Lo Presti A, Sernicola L, Farcomeni S, Ferrantelli F, Maggiorella MT, Mee ET, Rose NJ, Cella E, Ciccozzi M, Ensoli B, Borsetti A.

J Gen Virol. 2018 Dec;99(12):1717-1728. doi: 10.1099/jgv.0.001159. Epub 2018 Oct 12.

PMID:
30311877
3.

Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: An observational cross-sectional study.

Sanarico N, D'Amato S, Bruni R, Rovetto C, Salvi E, Di Zeo P, Chionne P, Madonna E, Pisani G, Costantino A, Equestre M, Tosti ME, Cenci A, Maggiorella MT, Sernicola L, Pontali E, Pansera A, Quattrocchi R, Carbonara S, Signorile F, Surace LA, Federzoni G, Garlassi E, Starnini G, Monarca R, Babudieri S, Rapicetta M, Pompa MG, Caraglia A, Ensoli B, Ciccaglione AR, Buttò S.

Medicine (Baltimore). 2016 Nov;95(44):e5257.

4.

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.

Ensoli F, Cafaro A, Casabianca A, Tripiciano A, Bellino S, Longo O, Francavilla V, Picconi O, Sgadari C, Moretti S, Cossut MR, Arancio A, Orlandi C, Sernicola L, Maggiorella MT, Paniccia G, Mussini C, Lazzarin A, Sighinolfi L, Palamara G, Gori A, Angarano G, Di Pietro M, Galli M, Mercurio VS, Castelli F, Di Perri G, Monini P, Magnani M, Garaci E, Ensoli B.

Retrovirology. 2015 Apr 29;12:33. doi: 10.1186/s12977-015-0151-y.

5.

Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines.

Titti F, Maggiorella MT, Ferrantelli F, Sernicola L, Bellino S, Collacchi B, Fanales Belasio E, Moretti S, Pavone Cossut MR, Belli R, Olivieri E, Farcomeni S, Compagnoni D, Michelini Z, Sabbatucci M, Sparnacci K, Tondelli L, Laus M, Cafaro A, Caputo A, Ensoli B.

PLoS One. 2014 Oct 30;9(10):e111360. doi: 10.1371/journal.pone.0111360. eCollection 2014.

6.

The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells.

Barillari G, Iovane A, Bacigalupo I, Labbaye C, Chiozzini C, Sernicola L, Quaranta MT, Falchi M, Sgadari C, Ensoli B.

Angiogenesis. 2014 Oct;17(4):831-8. doi: 10.1007/s10456-014-9430-9. Epub 2014 Apr 10.

PMID:
24719186
7.

Effect of MHC haplotype on immune response upon experimental SHIVSF162P4cy infection of Mauritian cynomolgus macaques.

Borsetti A, Ferrantelli F, Maggiorella MT, Sernicola L, Bellino S, Gallinaro A, Farcomeni S, Mee ET, Rose NJ, Cafaro A, Titti F, Ensoli B.

PLoS One. 2014 Apr 2;9(4):e93235. doi: 10.1371/journal.pone.0093235. eCollection 2014.

8.

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.

Monini P, Cafaro A, Srivastava IK, Moretti S, Sharma VA, Andreini C, Chiozzini C, Ferrantelli F, Cossut MR, Tripiciano A, Nappi F, Longo O, Bellino S, Picconi O, Fanales-Belasio E, Borsetti A, Toschi E, Schiavoni I, Bacigalupo I, Kan E, Sernicola L, Maggiorella MT, Montin K, Porcu M, Leone P, Leone P, Collacchi B, Palladino C, Ridolfi B, Falchi M, Macchia I, Ulmer JB, Buttò S, Sgadari C, Magnani M, Federico MP, Titti F, Banci L, Dallocchio F, Rappuoli R, Ensoli F, Barnett SW, Garaci E, Ensoli B.

PLoS One. 2012;7(11):e48781. doi: 10.1371/journal.pone.0048781. Epub 2012 Nov 13.

9.

Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy.

Borsetti A, Maggiorella MT, Sernicola L, Bellino S, Ferrantelli F, Belli R, Fulgenzi D, Mee ET, Rose NJ, Cafaro A, Ensoli B, Titti F.

Tissue Antigens. 2012 Jul;80(1):36-45. doi: 10.1111/j.1399-0039.2012.01875.x. Epub 2012 Apr 12.

PMID:
22494179
10.

A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.

Ferrantelli F, Maggiorella MT, Schiavoni I, Sernicola L, Olivieri E, Farcomeni S, Pavone-Cossut MR, Moretti S, Belli R, Collacchi B, Srivastava IK, Titti F, Cafaro A, Barnett SW, Ensoli B.

Vaccine. 2011 Apr 5;29(16):2918-32. doi: 10.1016/j.vaccine.2011.02.006. Epub 2011 Feb 21.

PMID:
21338681
11.

Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P.

Cafaro A, Bellino S, Titti F, Maggiorella MT, Sernicola L, Wiseman RW, Venzon D, Karl JA, O'Connor D, Monini P, Robert-Guroff M, Ensoli B.

J Virol. 2010 Sep;84(17):8953-8. doi: 10.1128/JVI.00377-10. Epub 2010 Jun 16.

12.

International multicenter study to assess a panel of reference materials for quantification of simian immunodeficiency virus RNA in plasma.

Ham C, Srinivasan P, Thorstensson R, Verschoor E, Fagrouche Z, Sernicola L, Ramos A, Titti F, Almond N, Berry N.

J Clin Microbiol. 2010 Jul;48(7):2582-5. doi: 10.1128/JCM.00082-10. Epub 2010 Apr 28.

13.

Generation of a human immunodeficiency virus type 1 chronically infected monkey B cell line expressing low levels of endogenous TRIM5alpha.

Ridolfi B, Catone S, Sgarbanti M, Sernicola L, Battistini A, Parolin C, Titti F, Borsetti A.

J Cell Physiol. 2009 Dec;221(3):760-5. doi: 10.1002/jcp.21914.

PMID:
19746418
14.

Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243).

Borsetti A, Baroncelli S, Maggiorella MT, Moretti S, Fanales-Belasio E, Sernicola L, Tripiciano A, Macchia I, Michelini Z, Belli R, Farcomeni S, Pavone-Cossut MR, Negri D, Caputo A, Bellino S, Butto S, Titti F, Cafaro A, Ensoli B.

Viral Immunol. 2009 Apr;22(2):117-24. doi: 10.1089/vim.2008.0082.

PMID:
19326998
15.

Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes.

D'Archivio M, Scazzocchio B, Filesi C, Varì R, Maggiorella MT, Sernicola L, Santangelo C, Giovannini C, Masella R.

FEBS Lett. 2008 Jun 25;582(15):2291-8. doi: 10.1016/j.febslet.2008.05.029. Epub 2008 Jun 2.

16.

IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer.

Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, Orsatti R, Ilari R, Sernicola L, Stellacci E, Ensoli B, Battistini A.

J Virol. 2008 Apr;82(7):3632-41. doi: 10.1128/JVI.00599-07. Epub 2008 Jan 23.

17.

Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.

Borsetti A, Baroncelli S, Maggiorella MT, Bellino S, Moretti S, Sernicola L, Belli R, Ridolfi B, Farcomeni S, Negri DR, Cafaro A, Ensoli B, Titti F.

Arch Virol. 2008;153(3):463-72. Epub 2007 Dec 15.

PMID:
18080858
18.

Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability.

Ridolfi B, Genovese D, Argentini C, Maggiorella MT, Sernicola L, Buttò S, Titti F, Borsetti A, Ensoli B.

Virus Genes. 2008 Feb;36(1):105-15. Epub 2007 Nov 30.

PMID:
18049888
19.

Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.

Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Pavone-Cossut MR, Macchia I, Farcomeni S, Tenner-Racz K, Racz P, Ensoli B, Titti F.

J Med Primatol. 2007 Aug;36(4-5):180-94.

PMID:
17669207
20.

Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus.

Negri DR, Borghi M, Baroncelli S, Macchia I, Buffa V, Sernicola L, Leone P, Titti F, Cara A.

J Gen Virol. 2006 Nov;87(Pt 11):3385-92.

PMID:
17030874
21.

Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.

Goletti D, Macchia I, Leone P, Pace M, Sernicola L, Pavone-Cossut MR, Maggiorella MT, Cafaro A, Ensoli B, Titti F.

Med Sci Monit. 2006 Oct;12(10):BR330-40. Epub 2006 Sep 25.

PMID:
17006396
22.

Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation.

Masella R, Varì R, D'Archivio M, Santangelo C, Scazzocchio B, Maggiorella MT, Sernicola L, Titti F, Sanchez M, Di Mario U, Leto G, Giovannini C.

FEBS Lett. 2006 May 1;580(10):2421-9. Epub 2006 Mar 30.

23.

T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.

Michelini Z, Negri DR, Baroncelli S, Catone S, Comini A, Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Mancini MG, Farcomeni S, Fagrouch Z, Ciccozzi M, Rovetto C, Liljestrom P, Norley S, Heeney J, Titti F.

J Med Primatol. 2004 Oct;33(5-6):251-61.

PMID:
15525326
24.

Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.

Maggiorella MT, Baroncelli S, Michelini Z, Fanales-Belasio E, Moretti S, Sernicola L, Cara A, Negri DR, Buttò S, Fiorelli V, Tripiciano A, Scoglio A, Caputo A, Borsetti A, Ridolfi B, Bona R, ten Haaft P, Macchia I, Leone P, Pavone-Cossut MR, Nappi F, Ciccozzi M, Heeney J, Titti F, Cafaro A, Ensoli B.

Vaccine. 2004 Sep 3;22(25-26):3258-69.

PMID:
15308348
25.

Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA.

Cara A, Maggiorella MT, Bona R, Sernicola L, Baroncelli S, Negri DR, Leone P, Fagrouch Z, Heeney J, Titti F, Cafaro A, Ensoli B.

Virology. 2004 Jul 1;324(2):531-9.

26.

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge.

Negri DR, Baroncelli S, Catone S, Comini A, Michelini Z, Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Mancini MG, Farcomeni S, Fagrouch Z, Ciccozzi M, Boros S, Liljestrom P, Norley S, Heeney J, Titti F.

J Gen Virol. 2004 May;85(Pt 5):1191-201.

PMID:
15105535
27.

HIV-1 Tat-based vaccines: from basic science to clinical trials.

Fanales-Belasio E, Cafaro A, Cara A, Negri DR, Fiorelli V, Butto S, Moretti S, Maggiorella MT, Baroncelli S, Michelini Z, Tripiciano A, Sernicola L, Scoglio A, Borsetti A, Ridolfi B, Bona R, Ten Haaft P, Macchia I, Leone P, Pavone-Cossut MR, Nappi F, Vardas E, Magnani M, Laguardia E, Caputo A, Titti F, Ensoli B.

DNA Cell Biol. 2002 Sep;21(9):599-610. Review.

PMID:
12396602
28.

Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markers.

Titti F, Zamarchi R, Maggiorella MT, Sernicola L, Geraci A, Negri DR, Borsetti A, Menin C, D'Andrea E, Modesti A, Masuelli L, Verani P, Chieco-Bianchi L, Amadori A.

J Med Virol. 2002 Sep;68(1):129-40.

PMID:
12210440
29.

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

Cafaro A, Titti F, Fracasso C, Maggiorella MT, Baroncelli S, Caputo A, Goletti D, Borsetti A, Pace M, Fanales-Belasio E, Ridolfi B, Negri DR, Sernicola L, Belli R, Corrias F, Macchia I, Leone P, Michelini Z, ten Haaft P, Buttò S, Verani P, Ensoli B.

Vaccine. 2001 Apr 6;19(20-22):2862-77.

PMID:
11282197
30.

SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine.

Cafaro A, Caputo A, Maggiorella MT, Baroncelli S, Fracasso C, Pace M, Borsetti A, Sernicola L, Negri DR, Ten Haaft P, Betti M, Michelini Z, Macchia I, Fanales-Belasio E, Belli R, Corrias F, Buttò S, Verani P, Titti F, Ensoli B.

J Med Primatol. 2000 Aug;29(3-4):193-208.

PMID:
11085582
31.

CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.

Borsetti A, Parolin C, Ridolfi B, Sernicola L, Geraci A, Ensoli B, Titti F.

J Virol. 2000 Jul;74(14):6689-94.

32.

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine.

Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, Baroncelli S, Pace M, Sernicola L, Koanga-Mogtomo ML, Betti M, Borsetti A, Belli R, Akerblom L, Corrias F, Buttò S, Heeney J, Verani P, Titti F, Ensoli B.

Nat Med. 1999 Jun;5(6):643-50.

PMID:
10371502
33.

Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

Sernicola L, Corrias F, Koanga-Mogtomo ML, Baroncelli S, Di Fabio S, Maggiorella MT, Belli R, Michelini Z, Macchia I, Cesolini A, Cioè L, Verani P, Titti F.

Virology. 1999 Apr 10;256(2):291-302.

34.

Detection of infectious simian immunodeficiency virus in B- and T-cell lymphomas of experimentally infected macaques.

Maggiorella MT, Monardo F, Koanga-Mogtomo ML, Cioè L, Sernicola L, Corrias F, Baroni CD, Verani P, Titti F.

Blood. 1998 May 1;91(9):3103-11.

PMID:
9558363
35.

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.

Titti F, Sernicola L, Geraci A, Panzini G, Di Fabio S, Belli R, Monardo F, Borsetti A, Maggiorella MT, Koanga-Mogtomo M, Corrias F, Zamarchi R, Amadori A, Chieco-Bianchi L, Verani P.

J Gen Virol. 1997 Oct;78 ( Pt 10):2529-39.

PMID:
9349474
36.

Vaccines against HIV.

Verani P, Titti F, Corrias F, Belli R, Di Fabio S, Geraci A, Konga-Mogtomo M, Maggiorella MT, Sernicola L.

J Biol Regul Homeost Agents. 1997 Jan-Jun;11(1-2):82-7. Review. No abstract available.

PMID:
9418170
37.

Vaccination of cynomolgus monkeys with whole inactivated or live-attenuated simian immunodeficiency virus.

Titti F, Sernicola L, Corrias F, Borsetti A, Maggiorella MT, Panzini G, Geraci A, Zamarchi R, Amadori A, Chieco-Bianchi L, Verani P.

Antibiot Chemother (1971). 1996;48:131-8. No abstract available.

PMID:
8726516
38.

Immunization of Macaca fascicularis with inactivated SIV preparations: challenge with human- or monkey-derived SIV and the effects of a longer immunization schedule.

Titti F, Koanga Mogtomo ML, Borsetti A, Geraci A, Sernicola L, Panzini G, Turillazzi GP, Baroncelli S, Giovannetti A, Zamarchi R, et al.

J Med Primatol. 1993 Feb-May;22(2-3):110-8.

PMID:
8411103
39.

Vaccination of pregnant cynomolgus monkeys with whole formalin-inactivated SIVmac251.

Titti F, Borsetti A, Geraci A, Sernicola L, Giuseppini L, Turillazzi GP, Pace M, Baroncelli S, Amadori A, Giovannetti A, et al.

J Med Primatol. 1992 Feb-May;21(2-3):91-8.

PMID:
1433272
40.

Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.

Rezza G, Titti F, Pezzotti P, Sernicola L, Lo Caputo S, Angarano G, Lazzarin A, Sinicco A, Rossi GB, Verani P.

J Biol Regul Homeost Agents. 1992 Jan-Mar;6(1):15-20.

PMID:
1359736
41.

HIV-1 and HIV-2 seropositivity among AIDS cases in Guinea.

Kourouma K, Foucault-Fretz C, Diallo MP, Sabbatani S, Rezza G, Titti F, Sernicola L, Verani P, Rossi GB.

AIDS. 1990 Dec;4(12):1299-300. No abstract available.

PMID:
2088411
42.

Detection of anti-HIV antibodies in preparations of human immunoglobulins. A collaborative group study.

Gentili G, Wirz M, Collotti C, Vicari G, Sernicola L, Verani P, Pizzocolo G, Crovari P, Icardi G, Ortona L, et al.

Ric Clin Lab. 1990 Apr-Jun;20(2):95-103.

PMID:
2371494
43.

Serological survey of human immunodeficiency virus (HIV) in Ethiopia.

Hailù K, Buttò S, Bekura D, Verani P, Titti F, Sernicola L, Rapicetta M, Pasquini P, Rossi GB.

J Med Virol. 1989 May;28(1):21-4.

PMID:
2786052
44.

High prevalence of antibodies to human immunodeficiency virus in heterosexual persons attending a sexually transmitted disease clinic in Italy.

Mele A, Verani P, Caprilli F, Gentili G, Stazi MA, Rezza G, Sernicola L, Franco E, Prignano G, Pasquini P.

Eur J Clin Microbiol Infect Dis. 1989 Mar;8(3):238-41.

PMID:
2540978
45.

Simultaneous seropositivity to HIV-1 and HIV-2 in Italian drug abusers.

Buttò S, Verani P, Titti F, Rezza G, Sernicola L, Rossi GB.

AIDS. 1988 Apr;2(2):139-40. No abstract available.

PMID:
3132945
46.

HIV, HTLV-1, and HBV infections in a cohort of Italian intravenous drug abusers: analysis of risk factors.

Titti F, Rezza G, Verani P, Buttò S, Sernicola L, Rapicetta M, Sarrecchia B, Oliva C, Rossi GB.

J Acquir Immune Defic Syndr. 1988;1(4):405-11.

PMID:
3216321

Supplemental Content

Loading ...
Support Center